Scotiabank Keeps Their Sell Rating on Transat AT V & VV (TRZ)
Scotiabank analyst Konark Gupta maintained a Sell rating on Transat AT V & VV (TRZ – Research Report) today and set a price target of C$2.00. The company's shares opened today at C$2.50.
Confident Investing Starts Here:
Gupta covers the Industrials sector, focusing on stocks such as Canadian National Railway, Secure Energy Services, and Canadian Pacific Kansas City. According to TipRanks, Gupta has an average return of 15.3% and a 63.81% success rate on recommended stocks.
In addition to Scotiabank, Transat AT V & VV also received a Sell from CIBC's Kevin Chiang in a report issued today. However, on June 6, TD Cowen upgraded Transat AT V & VV (TSX: TRZ) to a Buy.
Based on Transat AT V & VV's latest earnings release for the quarter ending January 31, the company reported a quarterly revenue of C$829.51 million and a GAAP net loss of C$122.53 million. In comparison, last year the company earned a revenue of C$785.5 million and had a GAAP net loss of C$60.98 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
Viking Therapeutics (VKTX) Rises on Expected Developments
We recently published a list of . In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other top-performing companies on Tuesday. Viking Therapeutics grew its share prices by 5.69 percent on Tuesday to finish at $29.14 apiece as investors loaded up positions while waiting for fresh catalysts from the series of global conferences that it is participating in this month. At present, investors are expecting updates and developments from the three-day 46th Annual Goldman Sachs Global Healthcare Conference in Florida on June 9 to 11. It is also set to participate in a one-on-one meeting at the Scotiabank Third Annual Healthcare Canadian Investor Day on June 17. In April this year, Viking Therapeutics, Inc. (NASDAQ:VKTX) soared following news that its competitor, Pfizer Inc., discontinued the development of its oral obesity medication, danuglipron, amid safety concerns. According to PFE, the decision came after a patient experienced a potential liver injury linked to the drug. A microbiologist in protective gear studying samples in a laboratory. The scrapped plans, however, spelled good news for Viking Therapeutics, Inc. (NASDAQ:VKTX), which is similarly underway with the development of an oral weight loss candidate called VK2735, with Pfizer Inc. now out of the competition. Overall, VKTX ranks 8th on our list of top-performing companies on Tuesday. While we acknowledge the potential of VKTX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 hours ago
- Yahoo
Need $1,000 Each Month? How Much You Need to Invest in a TFSA
Written by Amy Legate-Wolfe at The Motley Fool Canada Many Canadians dream of earning $1,000 a month in passive income. For those using a Tax-Free Savings Account (TFSA), that dream is tax-free. But how much do you really need to invest to make it happen? The answer depends on which stocks you choose and how much they pay. Today, we'll look at three solid dividend-paying stocks on the TSX, and figure out how much you'd need to invest in each one to hit that $1,000 monthly goal. Goeasy (TSX:GSY) is a major player in non-prime consumer lending. It helps Canadians access credit when traditional banks say no. That includes personal loans and leasing furniture or appliances. It's been around for years and has a reputation for strong performance and rising dividends. In the first quarter of 2025, the lender posted revenue of $318 million, up 22% from the same time last year. Net income came in at $52.6 million, with earnings per share of $3.08. That's up from $2.73 in Q1 2024. The dividend stock currently trades around $155 and offers a dividend yield of 3.8%. The dividend stock has raised its dividend every year for almost a decade, and its payout ratio remains sustainable. If you're comfortable with a bit more risk for more growth, goeasy could be a strong pick. Then there's Exchange Income (TSX:EIF). It's a unique dividend stock with operations in aerospace and aviation services, as well as manufacturing. In Q1 2025, the acquisition-oriented company reported revenue of $668.3 million, up 11% year over year. However, net income dipped slightly to $9.6 million from $11.8 million in Q1 2024, mostly due to acquisition costs and some seasonal slowdowns. The dividend is paid monthly and currently yields about 4.6%. Exchange Income has a long track record of paying dividends and growing through smart acquisitions. It's not as high-growth as goeasy, but it's dependable. Finally, we have Transcontinental (TSX:TCL.A). This dividend stock used to be known for its printing business, but now it's more focused on packaging. In Q2 2025, it brought in $703 million in revenue and net earnings of $24.4 million. While print still brings in revenue, it's the packaging division that's helping the company evolve. An investment may appeal to conservative investors who prefer a lower-risk business model. The dividend has remained stable, though it hasn't shown the kind of rapid growth that goeasy offers. So how much do you really need? The short answer for a mix of the three is a total investment of $263,085 at writing. Overall, it depends on the stock. Exchange Income gets you there the fastest, while Transcontinental takes longer. Goeasy lands in the middle but offers more long-term upside. Here's how investors might want to break it down for the best passive income, earning just under $12,000 a year, at $11,563 or $963.55 each month. Company Price Dividend/yr Shares Invested Income/yr EIF $57.83 $2.64 3,500 $202,400 $9,240 TCL.A $21.16 $0.90 2,500 $52,900 $2,250 GSY $155.70 $1.46 50 $7,785 $73 Total $263,085 $11,563 Achieving a $1,000 monthly income in a TFSA isn't easy, but it's definitely possible with the right combination of high-yield stocks and a long-term mindset. Whether you focus on growth, stability, or a mix of both, knowing your numbers is the first step. Let your TFSA work smarter, not harder. The post Need $1,000 Each Month? How Much You Need to Invest in a TFSA appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Transcontinental. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
13 hours ago
- Associated Press
Mogo Applies to Extend the Expiry Dates of Certain Warrants
VANCOUVER, British Columbia--(BUSINESS WIRE)--Jun 13, 2025-- Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ('Mogo' or the 'Company'), a digital wealth and payments business, today announced that it has applied to the Toronto Stock Exchange (the 'TSX') to extend the expiry date of 1,120,371 common share purchase warrants (the 'Warrants'). The Warrants were issued pursuant to the Company's US$27.5 million Registered Direct offering in December 2021 and are currently set to expire on June 13, 2025. The Warrants consist of 101,852 warrants with an exercise price of US$16.875 per common share and 1,018,519 warrants with an exercise price of US$14.10 per common share. Each Warrant entitles the holder thereof to acquire one common share of the Company and all other terms of the Warrants will remain the same. The Company is seeking to extend the expiry date of the Warrants to June 13, 2026. No insiders of the Company hold any of the Warrants, directly or indirectly. Finalization of this extension is subject to the approval of the TSX and the warrantholders. If such approvals are obtained, this extension will be effective on the date that is ten business days from the date of this press release (the 'Effective Date'), and the Warrants cannot be exercised during the period from June 13, 2025 up to the Effective Date. About Mogo Mogo Inc. (NASDAQ:MOGO; TSX:MOGO) is a financial technology company with three distinct business lines: wealth, lending, and payments. Our mission is to provide consumers with innovative financial solutions that drive long-term financial health and success. We operate with a differentiated approach in each business, leveraging technology, behavioral science, and financial tools to create unique value propositions in our respective markets. Our wealth and lending businesses are focused on the Canadian market, where we are the only subprime consumer lender that also offers a holistic wealth and investing solution. This unique integration is designed to help consumers transition from borrowing and debt to long-term wealth building. Separately, our payments business is operated through Carta Worldwide, a wholly owned subsidiary that provides modern card issuing and processing solutions, primarily in Europe. Forward-Looking Statements This news release may contain 'forward-looking statements' within the meaning of applicable securities legislation, including statements regarding the extension of the expiry date of the Warrants, including receipt of TSX and warrantholder approval. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements are typically identified by words such as 'may', 'will', 'could', 'would', 'anticipate', 'believe', 'expect', 'intend', 'potential', 'estimate', 'budget', 'scheduled', 'plans', 'planned', 'forecasts', 'goals' and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo's growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, many of which are outside of Mogo's control. For a description of the risks associated with Mogo's business please refer to the 'Risk Factors' section of Mogo's current annual information form, which is available at and Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. View source version on CONTACT: For further information: Craig Armitage Investor Relations [email protected] US Investor Relations Contact Lytham Partners, LLC Ben Shamsian New York | Phoenix [email protected] (646) 829-9701 KEYWORD: UNITED STATES NORTH AMERICA CANADA INDUSTRY KEYWORD: DATA MANAGEMENT TECHNOLOGY PROFESSIONAL SERVICES PAYMENTS DIGITAL CASH MANAGEMENT/DIGITAL ASSETS OTHER TECHNOLOGY DATA ANALYTICS SOFTWARE OTHER PROFESSIONAL SERVICES FINTECH FINANCE SOURCE: Mogo Inc. Copyright Business Wire 2025. PUB: 06/13/2025 08:55 PM/DISC: 06/13/2025 08:53 PM
